While progenitor exhausted cells can be reinvigorated by PD-1 blockade, terminally exhausted cells are considered unresponsive58 and patients with melanoma with higher proportions of progenitor exhausted cells in pre-therapy biopsies experienced a longer OS under combination therapy.59 This evidence concerns the gene PDCD1 and melanoma.